INS and type 1 diabetes mellitus: The treatment of type 1 diabetes (T1D) is rapidly evolving with the development of novel technologies such as continuous subcutaneous insulin infusion (CSII), continuous glucose monitoring (CGM), sensor augmented pumps (SAP) and hybrid closed‐loop (HCL) systems.1